NEW YORK -- More than 5 million people suffer from heart failure in the U.S., an estimated 156 of those die every day from advanced heart failure.
Twenty years ago, heart transplant was the only option; now, there are LVADs (left ventricular assist devices).
LVADs can serve as a temporary solution for patients waiting for a heart transplant or as ultimate treatment for those who aren't eligible for transplant.
Each year, NewYork-Presbyterian implants more than 100 LVADs. The main benefit from LVAD therapy is life.
Watch the video player above for more on LVAD treatment from doctors at NewYork-Presbyterian.
Advancements for heart failure sufferers